Eltrombopag 25 Mg (Generic)

What is Eltrombopag 25 Mg?

Eltrombopag 25 Mg is a prescription medication containing the active ingredient eltrombopag, developed by MSN Laboratories. It belongs to a class of drugs known as thrombopoietin receptor agonists, specifically designed to help increase platelet counts in certain medical conditions. This medicine plays an essential role in patient care by aiding those suffering from low platelet levels caused by specific health disorders.

The medication is primarily used to treat thrombocytopenia associated with immune thrombocytopenic purpura (ITP) and thrombocytopenia related to chronic hepatitis C virus (HCV) infection. Patients with these conditions often experience dangerously low platelet counts, which can lead to excessive bleeding and bruising. Eltrombopag 25 Mg helps mitigate these risks by stimulating platelet production.

Manufactured by MSN Laboratories, Eltrombopag 25 Mg is formulated for oral administration and is widely used under professional medical supervision. This product is available in Malaysia and is prescribed following diagnosis and thorough medical assessment. Proper use under guidance ensures optimal treatment outcomes and safety.

Uses of Eltrombopag 25 Mg

• Treatment of low platelet count in adults and children with immune thrombocytopenic purpura (ITP)
• Management of thrombocytopenia in patients with chronic hepatitis C infection to facilitate antiviral therapy
• Support platelet production in patients with conditions that impair bone marrow function

How Eltrombopag 25 Mg Works

Eltrombopag 25 Mg works by stimulating the thrombopoietin receptor on bone marrow cells. This action promotes the production and differentiation of megakaryocytes, the large cells responsible for producing platelets. With increased megakaryocyte activity, platelet production rises, leading to improved platelet counts in the bloodstream.

By enhancing the body’s natural ability to produce platelets, eltrombopag helps reduce the risk of bleeding and bruising associated with low platelet conditions. It does not treat the underlying cause of the thrombocytopenia but effectively manages the symptom of low platelets, improving patient quality of life and safety.

How to take Eltrombopag 25 Mg

Always follow your healthcare provider’s instructions when taking Eltrombopag 25 Mg. Usually, the medication is taken orally, once daily, with a glass of water. It is recommended to take it on an empty stomach, either 1 hour before or 2 hours after meals to maximize absorption. Avoid consuming foods or supplements containing calcium close to dosing time, as calcium can reduce the drug’s effectiveness.

Do not alter the dosage or stop the medication without consulting your physician. Regular blood tests are necessary to monitor platelet levels and adjust the dose accordingly.

Benefits of Eltrombopag 25 Mg

• Effectively increases platelet count in patients with low platelets
• Reduces risk of bleeding and associated complications
• Supports continuation of antiviral therapy in HCV patients
• Orally administered for ease and convenience
• Manufactured to high-quality standards by MSN Laboratories

Dosage and Administration

The typical recommended starting dose of Eltrombopag 25 Mg varies based on the patient’s condition, age, and platelet count response. For adults with ITP, the initial dose may start at 50 mg once daily; however, your doctor may adjust the dose to achieve a target platelet count. In patients with liver impairment or East Asian descent, lower starting doses might be recommended.

It is critical to follow the prescribed dosage and not exceed the recommended limits. Routine monitoring of blood platelet levels is essential to avoid adverse effects related to excessive platelet production.

Who Should Use Eltrombopag 25 Mg?

Eltrombopag 25 Mg is indicated for patients diagnosed with:

• Immune thrombocytopenic purpura (ITP) with inadequate response to other treatments
• Thrombocytopenia associated with chronic hepatitis C infection to support antiviral treatment
• Other bone marrow failure conditions as decided by the healthcare provider

Who Should Avoid Eltrombopag 25 Mg?

Eltrombopag 25 Mg should not be used by individuals who:

• Are allergic to eltrombopag or any ingredient in the formulation
• Have active blood clots or a history of thromboembolic events unless advised otherwise by a doctor
• Are pregnant or breastfeeding without consulting a healthcare professional
• Have severe liver problems not under strict medical supervision

Side Effects of Eltrombopag 25 Mg

• Headache
• Nausea
• Fatigue
• Diarrhea
• Upper respiratory tract infections
• Muscle or joint pain
• Abdominal pain
• Elevated liver enzymes
• Rare: Blood clots

Safety Advice

• Inform your doctor of all existing medical conditions before starting treatment
• Regular blood tests are required to monitor platelet levels and liver function
• Do not take supplements containing calcium close to dosing time
• Report any unusual bleeding or bruising immediately
• Do not discontinue medication without medical advice
• Keep out of reach of children

Drug Interactions

• Calcium-containing products can decrease absorption
• Concomitant use with warfarin requires careful monitoring
• Avoid combining with other medications that affect platelet function without doctor's guidance
• Inform your healthcare provider about all medications and supplements you are taking

Storage Instructions

Store Eltrombopag 25 Mg at room temperature, between 20°C and 25°C. Keep the medication in its original container, tightly closed, and away from moisture and direct sunlight. Do not store it in the bathroom. Keep out of reach of children and pets. Dispose of any unused or expired medicine properly as per local regulations.

Where to buy Eltrombopag 25 Mg in Malaysia?

Eltrombopag 25 Mg is available for purchase in accredited pharmacies across Malaysia. Always ensure you buy from licensed sources to guarantee genuine product quality. Your healthcare provider or pharmacist can guide you to reliable outlets or online platforms authorized to sell this medicine. Avoid unverified sellers to reduce the risk of counterfeit products.

Frequently Asked Questions (FAQ)

What is the price of Eltrombopag 25 Mg in Malaysia?

The price may vary depending on the pharmacy and location, but it is important to buy from authorized sellers to ensure authenticity. Consult local pharmacies or online licensed platforms for current pricing.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember unless it is near the time of your next dose. Do not double the dose to catch up. Contact your doctor if you are unsure.

Where can I find Eltrombopag 25 Mg for sale?

Eltrombopag 25 Mg can be purchased at licensed pharmacies or verified online pharmacies in Malaysia. Always ensure you have a valid prescription before buying.

Is Eltrombopag 25 Mg available in Malaysia?

Yes, Eltrombopag 25 Mg is available in Malaysia through licensed pharmaceutical distributors and pharmacies.

Can Eltrombopag 25 Mg be taken with other medications?

Some medicines, especially those containing calcium or blood thinners, may interact with eltrombopag. Always inform your healthcare provider about all medications you use.

How long does it take for Eltrombopag 25 Mg to work?

Patients may start to see an increase in platelet count within 1 to 2 weeks, but the response time can vary. Regular monitoring by your healthcare provider is essential.

Is Eltrombopag 25 Mg safe for children?

Eltrombopag is sometimes prescribed to children with ITP under specialist supervision. The dosage and safety measures differ; hence, it should only be used under pediatric specialist guidance.

Conclusion

Eltrombopag 25 Mg is a valuable pharmaceutical option for managing low platelet counts in patients with immune thrombocytopenic purpura and chronic hepatitis C-related thrombocytopenia. Manufactured by MSN Laboratories, this medication supports platelet production effectively and safely when used as directed. Proper medical supervision, adherence to dosage instructions, and regular monitoring are essential to maximize benefits and minimize risks. For patients in Malaysia seeking to manage thrombocytopenia, Eltrombopag 25 Mg offers a convenient and clinically proven solution, enhancing treatment outcomes and improving quality of life.